Comment
doi: 10.1056/NEJMc1501933.
New agents for hyperkalemia
- PMID: 25875265
- DOI: 10.1056/NEJMc1501933
Item in Clipboard
Comment
New agents for hyperkalemia
N Engl J Med.
.
No abstract available
Comment in
-
New agents for hyperkalemia.N Engl J Med. 2015 Apr 16;372(16):1570-1. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875263 No abstract available.
Comment on
-
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.N Engl J Med. 2015 Jan 15;372(3):211-21. doi: 10.1056/NEJMoa1410853. Epub 2014 Nov 21. N Engl J Med. 2015. PMID: 25415805 Clinical Trial.
Similar articles
-
New agents for hyperkalemia.N Engl J Med. 2015 Apr 16;372(16):1569. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875264 No abstract available.
-
New agents for hyperkalemia.N Engl J Med. 2015 Apr 16;372(16):1570. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875267 No abstract available.
-
New agents for hyperkalemia.N Engl J Med. 2015 Apr 16;372(16):1570. doi: 10.1056/NEJMc1501933. N Engl J Med. 2015. PMID: 25875266 No abstract available.
-
Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.Mayo Clin Proc. 2020 Feb;95(2):339-354. doi: 10.1016/j.mayocp.2019.05.019. Epub 2019 Oct 23. Mayo Clin Proc. 2020. PMID: 31668450 Review.
-
New therapies for hyperkalemia.Curr Opin Nephrol Hypertens. 2019 May;28(3):238-244. doi: 10.1097/MNH.0000000000000500. Curr Opin Nephrol Hypertens. 2019. PMID: 30865167 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
